Computerized Anxiety Treatment for Suicide

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

74 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-10-31

Study Completion Date

2016-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to test the effectiveness and usability of multiple computer-based treatments for mood and anxiety relevant risk factors. The target of the treatment is related to cognitive stress, which has been shown to be associated with a variety of negative mental health outcomes such as Post-Traumatic Stress Disorder, suicidal ideation, and substance use disorders.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cognitive Anxiety Sensitivity Treatment for Suicide

NCT01947179

Anxiety

COMPLETED NA

Mindfulness-Based Cognitive Therapy for Suicide Prevention

NCT01872338

Suicide

COMPLETED NA

Implementation of an Evidence Based Post-Traumatic Stress Disorder (PTSD) Treatment in Public Sector Settings

NCT01488539

Post-Traumatic Stress Disorder

COMPLETED NA

Computerized Cognitive Bias Intervention for Intolerance of Uncertainty

NCT02818296

Intolerance of Uncertainty; Anxiety

COMPLETED NA

Investigation of the Freespira Breathing System in the Treatment of Post Traumatic Stress Disorder (PTSD)

NCT03039231

Stress Disorders, Post-Traumatic

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

CATS is a newly developed computerized treatment targeting specific risk factors associated with anxiety symptoms and suicidal thoughts. Individuals will be asked to complete four appointments, where they will complete various self-report questionnaires as well as a newly developed computerized treatment targeting risk factors associated with anxiety.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anxiety Suicide

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

The anxiety risk reduction condition will be a combination of psychoeducation plus Cognitive Bias Modification (CBM-I) for anxiety sensitivity (AS). The psychoeducational component will focus on the nature of stress and its effect on the body. Interoceptive exposure (IE) exercises, designed to correct the conditioned fear to these bodily sensations, will be explained and practiced.

Group Type EXPERIMENTAL

Cognitive Anxiety Sensitivity Treatment

Intervention Type OTHER

Control

The control condition will be a combination of information about general health and wellness (e.g. diet, exercise etc.) plus an inert Cognitive Bias Modification (CBM-I) task.

Group Type PLACEBO_COMPARATOR

Physical Health Education Training

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cognitive Anxiety Sensitivity Treatment

Intervention Type OTHER

Physical Health Education Training

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Computerized Anxiety Treatment for Suicide (CATS)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Meet diagnostic criteria for a primary Axis 1 anxiety disorder or meet diagnostic criteria for a unipolar mood disorder along with an Axis 1 anxiety disorder.
* Show evidence of current suicidal ideation (BSS above 6.
* Show elevated AS indicated by scoring at or above the community sample mean on the ASI-Cog (above 9.

Exclusion Criteria

* No significant medical illness (e.g. sig cardiovascular disease, epilepsy, stroke).
* Current or past psychotic-spectrum disorders or uncontrolled bipolar disorder
* No current substance dependence
* Must be an English speaker.
* Must be 18 years or older.
* Must have normal or corrected vision
* Cannot begin treatment/therapy within 1 month of baseline.
* Cannot begin a new medication within 3 months of baseline.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No